Minimal Residual Disease After Autologous Stem-Cell Transplant for Patients With Myeloma: Prognostic Significance and the Impact of Lenalidomide Maintenance and Molecular Risk
暂无分享,去创建一个
G. Morgan | W. Gregory | M. Drayson | M. Jenner | F. Davies | G. Cook | G. Jackson | D. Cairns | R. de Tute | M. Kaiser | A. Rawstron | R. Owen | C. Pawlyn | John R. Jones | A. Hockaday | R. Henderson | T. Menzies